Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine vs prednisone for severe erosive oral lichen planus
ChiCTR2100042577Phase 4Recruiting
- Sponsor
- West China Hospital of Stomatology, Sichuan University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydroxychloroquine in oral lichen planus (OLP) (2 arms), sponsored by West China Hospital of Stomatology, Sichuan University. Primary endpoints: Lesion size, Pain level and 1 more. Started Feb 2021; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on ChiCTR2100042577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042577.